0001683168-19-001903.txt : 20190614 0001683168-19-001903.hdr.sgml : 20190614 20190614165053 ACCESSION NUMBER: 0001683168-19-001903 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190613 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20190614 DATE AS OF CHANGE: 20190614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RadNet, Inc. CENTRAL INDEX KEY: 0000790526 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133326724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33307 FILM NUMBER: 19899476 BUSINESS ADDRESS: STREET 1: 1510 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 3104787808 MAIL ADDRESS: STREET 1: 1510 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: PRIMEDEX HEALTH SYSTEMS INC DATE OF NAME CHANGE: 19930518 FORMER COMPANY: FORMER CONFORMED NAME: CCC FRANCHISING CORP DATE OF NAME CHANGE: 19920703 8-K 1 radnet_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

 

 

FORM 8-K

 

 

  

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): June 13, 2019

  

RadNet, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware 001-33307 13-3326724
(State or other jurisdiction
of incorporation)		 (Commission File
Number)		 (IRS Employer
Identification Number)

 

1510 Cotner Avenue

Los Angeles, California 90025

(Address of Principal Executive Offices) (Zip Code)

 

(310) 445-2800

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

     
Title of Each Class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $.0001 par value RDNT NASDAQ Global Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company   ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

   

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

At the Company’s Annual Meeting of Stockholders held on June 13, 2019, the stockholders considered and approved four proposals, each of which is described in more detail in the Company’s 2019 definitive proxy statement filed with the Securities and Exchange Commission on April 30, 2019 for the Annual Meeting of Stockholders.

 

The results detailed below represent the final voting results as certified by the Inspector of Elections:

 

Proposal 1

 

The stockholders elected the following seven directors to hold office until the 2020 Annual Meeting of Stockholders or until their successors are duly elected and qualified based on the following votes:

 

Director   For   Withheld   Broker Non-Votes
Howard G. Berger, M.D.   34,729,650   1,301,566   8,051,463 (total)
Marvin S. Cadwell   34,168,199   1,863,017    
John V. Crues, III, M.D.   33,364,429   2,666,787    
Norman R. Hames   34,103,788   1,927,428    
Lawrence L. Levitt   33,602,854   2,428,362    
Michael L. Sherman, M.D.   29,540,711   6,490,505    
David L. Swartz   33,598,705   2,432,511    

 

Proposal 2

 

The proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019 was approved based on the following votes:

 

For   Against   Abstentions
42,296,213   1,760,283   26,183

 

Proposal 3

 

The non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers disclosed in the Company’s 2019 definitive proxy statement was approved based on the following votes:

 

For   Against   Abstentions   Broker Non-Votes
35,134,447   808,626   88,143   8,051,463

 

Proposal 4

 

The non-binding advisory vote to consider the stockholder proposal requesting the Company adopt “majority voting” in uncontested elections of directors as disclosed in the Company’s 2019 definitive proxy statement was approved based on the following votes:

 

For   Against   Abstentions   Broker Non-Votes
21,964,481   12,777,255   1,289,480   8,051,463

 

 

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

  RadNet, Inc.
   
  By:  /s/ Deborah L. Saly
    Name: Deborah L. Saly
Title:  Vice President Legal Affairs and Associate General Counsel

 

Date:  June 14, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 3